Melatonin in doctors and nurses working nightshifts-the MIDNIGHT trial

B. M. V. J. Thottakam, N. R. Webster, G. Cameron, H. F. Galley

Research output: Contribution to journalAbstract

Abstract

The MIDNIGHT (Melatonin in doctors and nurses working nightshifts) trial was a randomised, placebo-controlled, double-blinded, cross-over pilot study to investigate the feasibility and acceptability of administration of exogenous melatonin (as Circadin) in medical and nursing staff working night shifts. Volunteers were randomised to receive 6 mg Circadin or placebo just before sleeping, after each of three consecutive night shifts. At the next set of shifts, at 4–6 weeks later, subjects received melatonin if they previously had placebo and vice versa. The target recruitment of 25 participants completing both arms of the study was achieved. Twelve participants (nine female/three male) received placebo followed by melatonin and 13 (eight female/five male) received melatonin first. All participants reported taking their trial medication and this concurred with drug accountability. Melatonin was not found in serum during the placebo phase. During the melatonin phase, median levels were 117 (10–1225), 83 (10–1430), and 309 (10–1050) pg ml–1, the morning after each of the three shifts, respectively; levels were highest after the third shift (P<0.01), suggesting some accumulation.
Original languageEnglish
Pages (from-to)E50-E51
Number of pages2
JournalBritish Journal of Anaesthesia
Volume122
Issue number3
Early online date13 Feb 2019
DOIs
Publication statusPublished - Mar 2019
EventMeeting of the BJA-Research-Forum - Dundee
Duration: 22 Nov 201823 Nov 2018

Cite this

Melatonin in doctors and nurses working nightshifts-the MIDNIGHT trial. / Thottakam, B. M. V. J.; Webster, N. R.; Cameron, G.; Galley, H. F.

In: British Journal of Anaesthesia, Vol. 122, No. 3, 03.2019, p. E50-E51.

Research output: Contribution to journalAbstract

Thottakam, B. M. V. J. ; Webster, N. R. ; Cameron, G. ; Galley, H. F. / Melatonin in doctors and nurses working nightshifts-the MIDNIGHT trial. In: British Journal of Anaesthesia. 2019 ; Vol. 122, No. 3. pp. E50-E51.
@article{c0f1a8b6743342d5826498e3f3e73b48,
title = "Melatonin in doctors and nurses working nightshifts-the MIDNIGHT trial",
abstract = "The MIDNIGHT (Melatonin in doctors and nurses working nightshifts) trial was a randomised, placebo-controlled, double-blinded, cross-over pilot study to investigate the feasibility and acceptability of administration of exogenous melatonin (as Circadin) in medical and nursing staff working night shifts. Volunteers were randomised to receive 6 mg Circadin or placebo just before sleeping, after each of three consecutive night shifts. At the next set of shifts, at 4–6 weeks later, subjects received melatonin if they previously had placebo and vice versa. The target recruitment of 25 participants completing both arms of the study was achieved. Twelve participants (nine female/three male) received placebo followed by melatonin and 13 (eight female/five male) received melatonin first. All participants reported taking their trial medication and this concurred with drug accountability. Melatonin was not found in serum during the placebo phase. During the melatonin phase, median levels were 117 (10–1225), 83 (10–1430), and 309 (10–1050) pg ml–1, the morning after each of the three shifts, respectively; levels were highest after the third shift (P<0.01), suggesting some accumulation.",
author = "Thottakam, {B. M. V. J.} and Webster, {N. R.} and G. Cameron and Galley, {H. F.}",
note = "Acknowledgement: BJA/RCoA Project Grant.",
year = "2019",
month = "3",
doi = "10.1016/j.bja.2018.10.046",
language = "English",
volume = "122",
pages = "E50--E51",
journal = "British Journal of Anaesthesia",
issn = "0007-0912",
publisher = "ELSEVIER APPL SCI PUBL LTD",
number = "3",

}

TY - JOUR

T1 - Melatonin in doctors and nurses working nightshifts-the MIDNIGHT trial

AU - Thottakam, B. M. V. J.

AU - Webster, N. R.

AU - Cameron, G.

AU - Galley, H. F.

N1 - Acknowledgement: BJA/RCoA Project Grant.

PY - 2019/3

Y1 - 2019/3

N2 - The MIDNIGHT (Melatonin in doctors and nurses working nightshifts) trial was a randomised, placebo-controlled, double-blinded, cross-over pilot study to investigate the feasibility and acceptability of administration of exogenous melatonin (as Circadin) in medical and nursing staff working night shifts. Volunteers were randomised to receive 6 mg Circadin or placebo just before sleeping, after each of three consecutive night shifts. At the next set of shifts, at 4–6 weeks later, subjects received melatonin if they previously had placebo and vice versa. The target recruitment of 25 participants completing both arms of the study was achieved. Twelve participants (nine female/three male) received placebo followed by melatonin and 13 (eight female/five male) received melatonin first. All participants reported taking their trial medication and this concurred with drug accountability. Melatonin was not found in serum during the placebo phase. During the melatonin phase, median levels were 117 (10–1225), 83 (10–1430), and 309 (10–1050) pg ml–1, the morning after each of the three shifts, respectively; levels were highest after the third shift (P<0.01), suggesting some accumulation.

AB - The MIDNIGHT (Melatonin in doctors and nurses working nightshifts) trial was a randomised, placebo-controlled, double-blinded, cross-over pilot study to investigate the feasibility and acceptability of administration of exogenous melatonin (as Circadin) in medical and nursing staff working night shifts. Volunteers were randomised to receive 6 mg Circadin or placebo just before sleeping, after each of three consecutive night shifts. At the next set of shifts, at 4–6 weeks later, subjects received melatonin if they previously had placebo and vice versa. The target recruitment of 25 participants completing both arms of the study was achieved. Twelve participants (nine female/three male) received placebo followed by melatonin and 13 (eight female/five male) received melatonin first. All participants reported taking their trial medication and this concurred with drug accountability. Melatonin was not found in serum during the placebo phase. During the melatonin phase, median levels were 117 (10–1225), 83 (10–1430), and 309 (10–1050) pg ml–1, the morning after each of the three shifts, respectively; levels were highest after the third shift (P<0.01), suggesting some accumulation.

UR - http://www.mendeley.com/research/melatonin-doctors-nurses-working-nightshiftsthe-midnight-trial

U2 - 10.1016/j.bja.2018.10.046

DO - 10.1016/j.bja.2018.10.046

M3 - Abstract

VL - 122

SP - E50-E51

JO - British Journal of Anaesthesia

JF - British Journal of Anaesthesia

SN - 0007-0912

IS - 3

ER -